Coronary Artery Disease: Optimal Lipoprotein(a) for Survival—Lower Is Better? A Large Cohort With 43,647 Patients

Overview of attention for article published in Frontiers in Cardiovascular Medicine, August 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 7 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,133 followers.

"Our finding provides a rationale for testing the lipoprotein(a)-reducing hypothesis with lower targets (even <15 mg/dL) in CAD outcome trials."

31 Aug 2021

Reply Repost Favourite

New Research: Coronary Artery Disease: Optimal Lipoprotein(a) for Survival—Lower Is Better? A Large Cohort With 43,647 Patients: Background: A high level of lipoprotein(a) can lead to a high risk of cardiovascular events or mortality.… https://t.co/p2Fipkf

31 Aug 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.